UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Reporter's Notebook] Drugmakers introduce creative PR formats amid Covid-19
More than five months have passed since Korea began battling against the Co...
by Lee Han-soo
|
2020-06-25 11:17
라인
[Reporter's Notebook] Korean firms found something missing in ‘virtual’ ASCO 2020
The 2020 American Society of Clinical Oncology (ASCO) Annual Meeting comple...
by Lee Han-soo
|
2020-06-08 16:54
라인
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
The Korean biopharmaceutical companies have recently increased their presen...
by Lee Han-soo
|
2019-12-11 17:37
라인
[Reporter's Notebook] Korean drugmakers should increase presence at global conventions
The 2019 American Society of Clinical Oncology (ASCO) Annual Meeting was be...
by Lee Han-soo
|
2019-06-21 15:57
라인
[Reporter’s Notebook]MFDS incapable of reviewing new drugs?
The most shocking news in the biotech industry in the first half was the mi...
by Lee Hye-seon
|
2019-04-29 16:12
라인
[Reporter’s Notebook] Concerns over TB risk rise amid more use of TNF-α inhibitors
Recently, pharmaceutical companies have developed various biological agents...
by Kim Yun-mi
|
2019-03-29 17:21
라인
[Reporter’s Notebook] Is Korean market unimportant for Samsung Bioepis?
“Please insert ‘severe’ in front of ‘acute pancreatitis’ in the headline an...
by Nam Doo-hyun
|
2018-08-16 14:24
라인
Pfizer Korea ignores reporters’ questions
“I do not think the questions are relevant to this occasion. Please check t...
by So Jae-hyeon
|
2018-06-01 15:18
라인
Stigmatizing mental illness leads to high suicide rate
Thirty-six Koreans commit suicide every day. That translates into one death...
by Marian Chu
|
2018-04-18 14:13
라인
Korea needs English medical media outlet
Korean pharmaceutical and biosimilar companies have recently stepped up the...
by Lee Han-soo
|
2018-03-09 17:46
라인
Why doesn’t Korea advertise condoms?
Korea takes up the lion’s share in manufacturing condoms worldwide but rank...
by Marian Chu
|
2018-01-09 11:00
라인
Korean food not as healthy as you think
With the Hallyu wave and a dictatorship ruled by a lunatic on its doorstep,...
by Constance Williams
|
2017-11-28 15:24
라인
Korea still one step behind in protecting foreigners
Despite the national slogan to attract more foreign tourists, the governmen...
by Lee Han-soo
|
2017-11-27 17:50
라인
Your hands can save a life; you have only to learn how
Kim Chu-young, a hiker in his mid-60s, was climbing up Mt. Achasan in south...
by Constance Williams
|
2017-11-01 15:59
라인
What does ‘gender equality’ have to do with this?
The Ministry of Gender Equality and Family, better known as the Ministry of...
by Marian Chu
|
2017-08-24 18:16
라인
Korean sex education fails younger generations
I remember my first HIV/AIDS commercial vividly over 13 years ago. It was o...
by Constance Williams
|
2017-07-19 17:28
라인
Give me rest or give me death
On Tuesday, a postman burned himself to death after his superiors changed h...
by Marian Chu
|
2017-07-12 17:05
라인
A letter to Pfizer CEO Michael Goettler
Dear CEO Michael Goettler,“There was no mention of Ibrance in the question ...
by Nam Doo-hyun
|
2017-07-04 18:57
라인
'But what of minorities?'
“About 200,000 foreigners are living in Korea who do not speak fluent Korea...
by Marian Chu
|
2017-06-16 08:00
라인
I asked a foreign doctor about Remsima and…
Is Celltrion’s biosimilar Remsima safe and effective?It may be a stupid que...
by Park Gi-taek
|
2017-03-30 14:55
-
1
2
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top